1 / 10

Aarkstore - Pharmaceutical & Healthcare Annual Deals

“Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. Browse full report @ http://bit.ly/1bsOo2V

JustinSterling
Download Presentation

Aarkstore - Pharmaceutical & Healthcare Annual Deals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category : Pharmaceuticals and Healthcare Aarkstore - Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012

  2. Summary “Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on Partnerships, Licensing Agreements, M&As, Equity/Debt Offerings, Private Equity and Venture Financing transactions registered in the pharmaceutical and healthcare industry in 2012. Additionally, the report provides information on the top venture capital and advisory firms in the pharmaceutical and healthcare industry. Data presented in this report is derived from Our proprietary in-house deals database and primary and secondary research. Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/109488/pharmaceutical-healthcare-annual-deals-analysis-ma-and-investments-trends-2012

  3. Scope - Analysis of the market trends for the pharmaceutical industry in the global arena. - Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and womens health segments. - Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry. - Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As. - Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

  4. Reasons to buy - Enhance your decision making capability in a more rapid and time sensitive manner. - Find out the major deal performing segments for investments in your industry. - Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets. - Identify companies that are aggressively looking to raise capital in the market - Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry. - Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies. - Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

  5. Table of Content 1.1 List of Tables 1.2 List of Figures 2 Pharmaceutical & Healthcare, Global, Deals Summary 2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2012 2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2012 by Quarter 2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2012 2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2012 2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2012 2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2012 2.5.1 Abbott Completes Private Placement of Notes for $14.7 Billion

  6. List of Tables Table 1: Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2008 - 2012 Table 2: Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2012-Q4 2012 Table 3: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (%), 2012 Table 4: Pharmaceuticals & Healthcare, Top Deals, Global, 2012 Table 5: Pharmaceuticals & Healthcare, Global, Top Deal Makers, Number of Deals and Deal Value (US$ m), 2012 Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2008 - 2012 Table 7: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2012-Q4 2012 Table 8: Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2012 Table 9: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2012

  7. List of Figures Figure 1: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2008- 2012 Figure 2: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2012-Q4 2012 Figure 3: Pharmaceuticals & Healthcare, Global, Number of Deals (%), 2012 Figure 4: Pharmaceuticals & Healthcare, Global, Deal Values (%), 2012 Figure 5 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2008 - 2012 Figure 6 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2012-Q4 2012 Figure 7: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2012 Figure 8: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2008 - 2012 Figure 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2012-Q4 2012

  8. Related reports: • Essential Thrombocythemia - Pipeline Review, H1 2015 • Oligodendroglioma - Pipeline Review, H1 2015 • Inclusion Body Myositis (IBM) - Pipeline Review, H1 2015 • Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015 • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015 • Fabry Disease-Pipeline Insights, 2015 • Ocular Hypertension-Pipeline Insights, 2015 • Shock-Pipeline Insights, 2015 • Fallopian Tube Cancer-Pipeline Insights, 2015 • Ocular Inflammation-Pipeline Insights, 2015

  9. Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2012 Published: Mar 2013 | 120 Pages “Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. Price

  10. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news

More Related